It’s been just revealed that Remdesivir covid-19 treatment drug has been banned for export by India. Check out the latest reports about all this.
DW notes that Indian authorities temporarily halted exports of the antiviral drug remdesivir on Sunday, as a surge in coronavirus infections has put a strain on the supply.
It seems that India reported its biggest-ever daily spike of 152,879 cases on Sunday, even as authorities launched a four-day “vaccine festival” to intensify the campaign in the country.
Health authorities have stated that the surge in cases had led to a “sudden spike in demand” for remdesivir and that there was a “potential of further increase in this demand in the coming days.”
It’s been also reported that seven firms in India produce the drug owned by US pharma giant Gilead. It showed early promise as a treatment for COVID-19, but the World Health Organization said the drug had “little or no effect” on mortality.
Check out the complete story in the original article.
Pfizer vaccine and the South African coronavirus variant
Earlier today, it’s been reported that the Pfizer vaccine is not that effective when it comes to the South African variant of the coronavirus.
CNBC just revealed that the coronavirus variant first discovered in South Africa is able to evade some of the protection of the Pfizer-BioNTech vaccine, according to a new Israeli study, which has not yet been peer-reviewed.
“Researchers at Tel Aviv University and Clalit, the largest healthcare organization in Israel, examined nearly 400 people who had tested positive for Covid-19 after receiving at least one dose of the vaccine. They compared them to the same number of people who were infected and unvaccinated,” the online publication mentioned above notes.
Stay tuned for more news about the latest important issues regarding coronavirus around the world.